Events

Show past events
September 13

Dissertation: Jukka Vanhanen

Jukka Vanhanen, University of Helsinki, Faculty of Medicine
Transcranial magnetic stimulation and neuromodulation in disorders of the sensorimotor system

Opponent: Professor Jean-Pascal Lefaucheur, Université Paris-Est Créteil,Créteil, France




Start time: 13/09/2024 12:00
End time: 13/09/2024 14:00
Duration: 2 hours
Location: Biocenter 2, Viikinkaari 5, lecture hall 2041
Type: Dissertation
Organization: UH, Faculty of Medicine
Contact person: jukka.vanhanen@helsinki.fi
Further information: https://helda.helsinki.fi/items/b788e87d-2ad7-4c88-a04d-47577125b50c
Online meeting link: https://helsinki.zoom.us/j/69084058495
September 13

Dissertation: Wafa Wahbi

Wafa Wahbi, University of Helsinki, Faculty of Medicine
Advancing Preclinical Evaluation : 3D and Zebrafish Models for Head and Neck Cancer Treatment Testing

Opponent: PhD Kirsi Ketola, University of Eastern Finland



Start time: 13/09/2024 13:00
End time: 13/09/2024 15:00
Duration: 2 hours
Location: Biomedicum1, lecture hall 2, Haartmaninkatu 8, 00290 Helsinki
Type: Dissertation
Organization: UH, Faculty of Medicine
Contact person: wafa.wahbi@helsinki.fi
Further information: https://helda.helsinki.fi/items/7f70cf77-637c-4b2a-a91d-3e0c436f6f5d
Online meeting link:
September 13

Dissertation: Marika Smeds

Marika Smeds, University of Helsinki, Faculty of Medicine

Spontaneous intracerebral hemorrhage : oxygen treatment, prognosis and economical burden of patients requiring intensive care

Opponent: professor Andrew Udy, Monash University

Start time: 13/09/2024 13:00
End time: 13/09/2024 15:00
Duration: 2 hours
Location: Kielikeskus, Juhlasali, Fabianinkatu 26, Helsinki
Type: Dissertation
Organization: UH, Faculty of Medicine
Contact person: marika.smeds@helsinki.fi
Further information: https://helda.helsinki.fi/items/77d1a08f-c2b5-44c3-ae74-15c57c30937d
Online meeting link:
September 18

Studia Medicina: Suolistosyöpä yleistyy mutta ennuste paranee

Suolistosyöpä yleistyy mutta ennuste paranee

professori Perttu Arkkila HY/HUS Suolistosyövän seulonnan avulla varhaisempaan diagnoosiin

Osastonylilääkäri, dosentti Anna Lepistö HY/HUS Suolistosyövän hoito tänään

professori emerita Helena Isoniemi HY/HUS: Etäpesäke maksassa – onko potilaalla toivoa?

Puheenjohtajana toimii erikoislääkäri, dosentti Johanna Louhimo HY/HUS
Start time: 18/09/2024 17:00
End time: 18/09/2024 19:00
Duration: 1 hour
Location: Biomedicum1, lecture hall 1, Haartmaninkatu 8, 00290 Helsinki
Type: Seminar
Organization: Biomedicum Helsinki Foundation
Contact person: saatio@biomedicum.fi
Further information: https://biomedicum.com/fi/osallistu/tapahtumat/studia-medicina/
Online meeting link:
September 20

iCAN science seminar: Dr. Daniel Hodson

Deciphering the Genomics of Aggressive Lymphomas
Speaker: Dr. Daniel Hodson, MD, PhD
Host: Prof. Sirpa Leppä

Minibio:

 Dr Hodson studied medicine at Cambridge and Oxford Universities before training in clinical haematology in Cambridge. He undertook a University of Cambridge PhD in molecular immunology supervised by Dr Martin Turner at the Babraham Institute. In 2010 he moved as a Kay Kendall Leukaemia Fund (KKLF) Post-doctoral Fellow to the lab of Dr Louis Staudt at the National Cancer Institute, NIH, USA to study the functional genomics of aggressive B cell lymphoma. In 2015 he was awarded a Medical Research Council (MRC) Clinician Scientist Fellowship and returned to Cambridge to establish a research group in the Welcome MRC Cambridge Stem Cell Institute, University of Cambridge. In 2021 he was awarded a Cancer Research UK Senior Research Fellowship and in 2023 a European Research Council Consolidator award.

The Hodson Group researches the molecular mechanisms that underlie lymphomagenesis with a view to identifying new targets for designer anti-lymphoma therapies. Key themes in his lab are molecular profiling (especially ctDNA) to resolve genetic heterogeneity of DLBCL, novel approaches to model the functional genetics of lymphoma, and the mechanistic contribution of RNA helicases in lymphomagenesis. Dr Hodson is also a practising clinician and an honorary Haematology consultant. He runs an active portfolio of clinical trials to study the effect of novel therapies in patients with lymphoma and chairs the UK NCRI Lymphoma Translational Science Subgroup.


Start time: 20/09/2024 09:00
End time: 20/09/2024 10:00
Duration:
Location: Biomedicum Helsinki 1, meeting room Skutsi
Type: Seminar
Organization: iCAN Flagship Team
Contact person: ican-comms@helsinki.fi
Further information: https://ican.fi/news-events/ican-science-seminar-on-deciphering-the-genomics-of-aggressive-lymphomas-with-dr-daniel-hodson/
Online meeting link: https://helsinki.zoom.us/j/64804986682?pwd=ME8rOVhucnQ5YXE1VVdpck5BN25BZz09